Table 5.
Spontaneous USe | Total Sample (n = 12) | +p Value | Virtual Reality MT (n = 6) | p Value | Conventional MT (n = 6) | p Value |
---|---|---|---|---|---|---|
Indep. Task | ||||||
Week 0 | 23.5 (15, 28) | 0.12 | 24 (21, 28) | 20 (15, 27) | ||
Week 4 | 24.5 (15, 29) | 0.02 * | 26 (23, 29) | 0.02 * | 19.5 (15, 24) | 0.78 |
No indep. Task | ||||||
Week 0 | 2 (0, 9) | 0.10 | 1 (0, 8) | 4 (2, 9) | ||
Week 4 | 2.5 (0, 7) | 0.19 | 0.5 (0, 5) | 0.18 | 5 (0, 7) | 0.28 |
No rel. Task | ||||||
Week 0 | 2.5 (0, 8) | 0.75 | 5 (0, 7) | 2 (0, 8) | ||
Week 4 | 1.5 (0, 8) | 0.14 | 3 (0, 3) | 0.13 | 6.5 (0, 8) | 0.28 |
Non-use AH | ||||||
Week 0 | 0 (0, 3) | 0.90 | 0 (0, 3) | 0 (0, 2) | ||
Week 4 | 0 (0, 3) | 0.41 | 0 (0, 3) | 1.00 | 0 (0, 0) | 0.32 |
Use AH support | ||||||
Week 0 | 2 (0, 21) | 0.37 | 1 (0, 18) | 4 (0, 21) | ||
Week 4 | 3.5 (0, 13) | 0.32 | 0.5 (0, 10) | 0.46 | 7.5 (0, 13) | 0. 41 |
Use AH grasp | ||||||
Week 0 | 19 (0, 27) | 0.14 | 20 (3, 27) | 16 (0, 27) | ||
Week 4 | 17.5 (0, 29) | 0.04 * | 24 (12, 29) | 0.04 * | 15.5 (2, 17) | 0.32 |
Efficacy | ||||||
Week 0 | 3.3 (2,3, 4) | 0.74 | 3.2 (2.3, 3.8) | 3.3 (3.1, 4) | ||
Week 4 | 3.5 (2.3, 4) | 0.59 | 3.7 (2.3, 4) | 0.79 | 3.5 (2.9, 4) | 0.70 |
Task time | ||||||
Week 0 | 3.4 (1.9, 4) | 0.19 | 3.5 (3.2, 4) | 3.3 (1.9, 4) | ||
Week 4 | 3.7 (1.7, 4) | 0.39 | 3.8 (3.1, 4) | 0.58 | 3.6 (1.7, 4) | 0.45 |
Disconfort | ||||||
Week 0 | 3.9 (2.9, 4) | 0.55 | 3.9 (3.6, 4) | 3.7 (2.9, 4) | ||
Week 4 | 3.9 (2.9, 4) | 0.17 | 3.9 (3.5, 4) | 0.85 | 3.9 (2.9, 4) | 0.32 |
Virtual Reality MT: Virtual Reality Mirror Therapy; Conventional MT: Conventional Mirror Therapy; Indep. Task: Independent Tasks; No Independ. Tasks: No independent tasks; No rel. Tasks: No relevant tasks; No use AH: No use of Affected Hand; Use AH: Use of the Affected Hand; Use AH with support: Use of the Affected Hand with support; Use AH with grasp: Use of the Affected Hand with grasp. Independent task, no-independent task, no relevant task, non-use AH, Use AH with support, and use AH with grasp are expressed in total number of tasks. Efficacy, task time and discomfort are expressed in a 4-point scale (1–4; 1: lowest score, 4: highest score). Values are expressed in median (interquartile range; (IQR). + Statistically Significant Difference (intergroup difference assessed with Mann-Whitney U-test) when p value < 0.05. * Statistically Significant Difference (pre-post intragroup difference assessed with Wilcoxon’s test) when p value < 0.05.